News Guangdong Hybribio Biotech Co.,Ltd.

Equities

300639

CNE100002N51

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
6.2 ^CNY	+2.31%		+1.47%	-33.62%

Apr. 26	Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 24	Guangdong Hybribio Biotech Co.,Ltd. Proposes Final Dividend for the Year 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Guangdong Hybribio Biotech Co.,Ltd. Proposes Final Dividend for the Year 2023	Apr. 23	CI
Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 23	CI
Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.	Apr. 01	CI
Guangdong Hybribio Biotech, Subsidiary Get Patent from Brazil for Isolation Method	Mar. 22	MT
Hybribio Calls for Raising International HPV Awareness	Mar. 04	AQ
Hybribio Biotech's Unit Secures Registration Certificate for Nucleic Acid Analysis System	Feb. 23	MT
Guangdong Hybribio Biotech Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.	Feb. 05	CI
Guangdong Hybribio Biotech Co.,Ltd. authorizes a Buyback Plan.	Feb. 04	CI
Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Two Guangdong Hybribio Biotech Units Get Licenses from Drug Regulator	23-09-04	MT
Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Guangdong Hybribio Biotech Registers Gene Testing Kit	23-08-18	MT
Hybribio Showcases Cutting-Edge Cervical Cancer HPV Diagnostic Solutions At ADLM 2023	23-07-31	CI
Hybribio Biotech Appoints Chief Medical Officer	23-06-27	MT
Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on October 26, 2022.	23-05-24	CI
Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback announced on October 26, 2022 has closed with 5,937,000 shares, representing 0.91% for CNY 100 million.	23-05-22	CI
Guangdong Hybribio Biotech Co.,Ltd. Announces Cash Dividend on A Shares for Year 2022, Payable on May 22, 2023	23-05-12	CI
Guangdong Hybribio Biotech Co.,Ltd. Approves Cash Dividend for 2022	23-05-08	CI
Hybribio Biotech Patents HPV Gel in Indonesia	23-05-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Guangdong Hybribio Biotech Co.,Ltd.

Equities

300639

CNE100002N51

Summary

Filters